MedPath

Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease

Phase 3
Completed
Conditions
Degenerative Disc Disease
Interventions
Device: HEALOS and Leopard Cage
Device: Leopard Cage and Autograft
Registration Number
NCT00316121
Lead Sponsor
Advanced Technologies and Regenerative Medicine, LLC (ATRM)
Brief Summary

The purpose of this study is to determine the safety and effectiveness of HEALOS compared with autograft using the transforaminal lumbar interbody fusion (TLIF) method.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
138
Inclusion Criteria
  • Persistent back and/or leg pain refractory to 6 months of non-surgical therapy
  • Male or female 18 to 70 years of age (inclusive)
  • Objective evidence of significant disc degeneration at one or two adjacent lumbar level(s) from L2/L3 to L5/S1
Exclusion Criteria
  • Significant disc degeneration at more than two adjacent levels
  • Greater than Grade II spondylolisthesis
  • Prior fusion surgery of the lumbar spine (prior discectomies and intradiscal electrothermal therapy [IDET] are allowed)
  • Insulin-dependent diabetes mellitus
  • Pregnant or lactating, or wishes to become pregnant within the 24 month duration of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1HEALOS and Leopard Cage-
2Leopard Cage and Autograft-
Primary Outcome Measures
NameTimeMethod
Subject Success (Success is Defined Only if All of These Criteria Are Fulfilled)24 months

Success is bridging bone, slip of study level versus adjacent levels less than 3 millimeters, angulation less than 5 degrees, 15 point increase in Oswestry Disability Index (ODI) (how back/leg trouble affects activities of daily living), no new problems in motor strength in legs, presence/absence of pain on leg raise, sensation intact on thigh/leg/foot reflexes of the knees/ankles, no permanent/serious complications, no revision/removal/reoperation/supplemental fixation. The ODI is on a 6 point scale from 0 (no pain/no impact on duties) to 5 (worst pain ever/unable to perform duties).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath